An interventional study of Cognitive Processing Therapy and Prolonged Exposure in PTSD - Post Traumatic Stress Disorder, sponsored by Rush University Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Rush University Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 114 studies in Combat Disorders with a site in United States — 41 open to participants now, 44 under way, 2 of them phase 3. Combat Disorders · United States.
Among the 114 studies in Combat Disorders with a site in United States, this one is the 5th largest by planned enrollment of the 100 interventional ones that give a count, is one of 22 that started in 2025, is one of 72 with no phase, reaches primary completion later than 35 of the 43 other live ones, and was the 70th registered.
204 studies on the registry are indexed under Combat Disorders; 93 are open to participants now.
Browse Combat Disorders studies →41 of the 114 studies in Combat Disorders with a site in United States are open now. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–55
COMPASS Pathways · Sites in United States, Canada
Ages 18+
Summit Hyperbarics and Wellness · Sites in United States
Ages 18–75
The University of Texas Health Science Center at San Antonio · Sites in United States
Healthy volunteers
Cognitive FX · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 53 Combat Disorders studies recruiting now, 22 (42%) set no upper age limit and 26 (49%) stop at 75 or younger; 10 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
114 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 16 · Phase 3 5 · Phase 4 3
First in 2004; this study’s year is marked. 22 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 400 is above the median of 72 across 171 interventional studies indexed under Combat Disorders.
Median enrollment 74 across the 100 interventional studies, 111 across the 14 observational. Of the 61 that completed or were terminated, 21 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 114 have an industry lead sponsor. The 10 most frequent:
Rush University Medical Center is the lead sponsor of 397 studies on the registry; 60 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 26 (81%) have results posted.
Rush University Medical Center has 2 studies filed under Combat Disorders — fewer than ten, so there is no comparison to draw.
15 of the studies in Combat Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06228391Minneapolis Veterans Affairs Medical CenterKetamine Treatment for PTSD and MDD in TBI | 2026-12 |
| NCT07463703Cognitive FXAccelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder | 2026-12 |
| NCT05414708Walter Reed National Military Medical CenterArt Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms | 2026-12 |
| NCT07523685Acacia ClinicsNon-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD) | 2027-01 |
| NCT07336251White River Junction Veterans Affairs Medical CenterTranscranial Magnetic Stimulation in Veterans With PTSD | 2027-01 |
Add all 15 to your calendar (.ics) → With an account.
Among the 114 studies in Combat Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will look at:
How practical it is to offer another round of proven therapy. How effective different therapy options are for people who didn't respond to the first treatment.
The goal is to improve personalized care by:
Identifying factors that might predict how someone will respond to a second treatment.
Creating a simple tool to spot people who might not respond to treatment early, so they can start a different option sooner.
The findings will help improve PTSD care by offering better follow-up treatments and matching patients with the approach that works best for them.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants will start in Arm 1 where they receive 10-sessions of Cognitive Processing Therapy.
Behavioral: Cognitive Processing Therapy
At one-week follow up after initial Cognitive Processing Therapy, participants whose scores are 28 or above on the PTSD Checklist for DSM-5 will be offered a subsequent course of treatment.
Behavioral: Cognitive Processing Therapy · Behavioral: Prolonged Exposure · Behavioral: Skills Training for Affective and Interpersonal Regulation
Cognitive Processing Therapy is a first-line intervention for the treatment of PTSD that focuses on changing unhelpful patterns of thinking.
Also known as: CPT
Prolonged Exposure is an evidence-based treatment for PTSD that helps to reduce the intensity of distress by gradually exposing participants to trauma-related memories, feelings, and situations in real life.
Also known as: PE
Skills Training for Affective and Interpersonal Regulation (STAIR) is a evidence-based treatment geared towards helping regulate emotional and interpersonal needs of those with PTSD.
Also known as: STAIR
PTSD Checklist for DSM-5 (PCL-5)
A self-report measure of PTSD symptom severity
Time frame: Baseline to 6 month follow up
Clinician Administered PTSD Scale for DSM-5
A clinician-rated assessment of PTSD
Time frame: Baseline to 6 mont follow up
Plan to share: No
Started Oct 2025 (actual). Primary completion is estimated for Jun 2029, 43 months after the start.
Of 76 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 43 months is above that.
Counting every sponsor, half of 82 studies reached it within 25 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rush University Medical Center →